» Articles » PMID: 36875468

Allosteric Modulation of G Protein-coupled Receptor Signaling

Overview
Specialty Endocrinology
Date 2023 Mar 6
PMID 36875468
Authors
Affiliations
Soon will be listed here.
Abstract

G protein-coupled receptors (GPCRs), the largest family of transmembrane proteins, regulate a wide array of physiological processes in response to extracellular signals. Although these receptors have proven to be the most successful class of drug targets, their complicated signal transduction pathways (including different effector G proteins and β-arrestins) and mediation by orthosteric ligands often cause difficulties for drug development, such as on- or off-target effects. Interestingly, identification of ligands that engage allosteric binding sites, which are different from classic orthosteric sites, can promote pathway-specific effects in cooperation with orthosteric ligands. Such pharmacological properties of allosteric modulators offer new strategies to design safer GPCR-targeted therapeutics for various diseases. Here, we explore recent structural studies of GPCRs bound to allosteric modulators. Our inspection of all GPCR families reveals recognition mechanisms of allosteric regulation. More importantly, this review highlights the diversity of allosteric sites and presents how allosteric modulators control specific GPCR pathways to provide opportunities for the development of new valuable agents.

Citing Articles

Identification of a Cannabinoid Receptor 2 Allosteric Site Using Computational Modeling and Pharmacological Analysis.

Farooq Z, Delre P, Iliadis S, Mangiatordi G, Contino M, Howell L ACS Pharmacol Transl Sci. 2025; 8(2):423-434.

PMID: 39974643 PMC: 11833715. DOI: 10.1021/acsptsci.4c00547.


Effect of a Low-Molecular-Weight Allosteric Agonist of the Thyroid-Stimulating Hormone Receptor on Basal and Thyroliberin-Stimulated Activity of Thyroid System in Diabetic Rats.

Derkach K, Pechalnova A, Sorokoumov V, Zorina I, Morina I, Chernenko E Int J Mol Sci. 2025; 26(2).

PMID: 39859419 PMC: 11766125. DOI: 10.3390/ijms26020703.


Intracellular Pocket Conformations Determine Signaling Efficacy through the μ Opioid Receptor.

Cooper D, DePaolo-Boisvert J, Nicholson S, Gad B, Minh D J Chem Inf Model. 2025; 65(3):1465-1475.

PMID: 39824514 PMC: 11817682. DOI: 10.1021/acs.jcim.4c01437.


Intracellular pocket conformations determine signaling efficacy through the opioid receptor.

Cooper D, DePaolo-Boisvert J, Nicholson S, Gad B, Minh D bioRxiv. 2024; .

PMID: 39677660 PMC: 11642773. DOI: 10.1101/2024.04.03.588021.


Metabotropic Glutamate Receptor 5: A Potential Target for Neuropathic Pain Treatment.

Manengu C, Zhu C, Zhang G, Tian M, Lan X, Tao L Curr Neuropharmacol. 2024; 23(3):276-294.

PMID: 39411936 PMC: 11808587. DOI: 10.2174/1570159X23666241011163035.


References
1.
Paila Y, Chattopadhyay A . Membrane cholesterol in the function and organization of G-protein coupled receptors. Subcell Biochem. 2010; 51:439-66. DOI: 10.1007/978-90-481-8622-8_16. View

2.
Davey A, Leach K, Valant C, Conigrave A, Sexton P, Christopoulos A . Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor. Endocrinology. 2012; 153(3):1232-41. DOI: 10.1210/en.2011-1426. View

3.
Lazareno S, Dolezal V, Popham A, Birdsall N . Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity. Mol Pharmacol. 2004; 65(1):257-66. DOI: 10.1124/mol.65.1.257. View

4.
Lemberger L . Potential therapeutic usefulness of marijuana. Annu Rev Pharmacol Toxicol. 1980; 20:151-72. DOI: 10.1146/annurev.pa.20.040180.001055. View

5.
Dore A, Okrasa K, Patel J, Serrano-Vega M, Bennett K, Cooke R . Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain. Nature. 2014; 511(7511):557-62. DOI: 10.1038/nature13396. View